Benefits
Free radical scavenging and lower oxidative stress in laboratory studies
In test-tube assays epsilon-viniferin neutralizes DPPH free radicals, though less strongly than vitamin E. In cultured cells, including nerve and skin cells placed under stress, it lowers reactive oxygen species and helps protect the cell's energy machinery. These are laboratory measures, not results from people, and the relevance to the body is unknown.
Mitochondrial energy production in cell studies
In cell studies epsilon-viniferin activates AMP-activated protein kinase (AMPK), a cellular energy sensor, and raises levels of the mitochondrial protein SIRT3. In stressed nerve cells this went along with more ATP, a steadier mitochondrial membrane and signs of new mitochondria forming. All of this is laboratory work in cells rather than in people.
Blood sugar and blood lipid measures in animal studies
When given by mouth to diabetic rats fed a high-fat diet, epsilon-viniferin was followed by lower fasting blood sugar, total cholesterol, triglycerides and LDL cholesterol, plus better glucose handling, changes the researchers linked to AMPK activation in the liver. This is rodent work over several weeks and has not been tested in people.
Fat cell development and fat storage in preclinical models
In fat cells grown in the laboratory and in mice, epsilon-viniferin has been reported to curb the formation of new fat cells and reduce fat accumulation. Reviews describe this work as promising but preliminary and call for the animal findings to be confirmed and then tested in people. No human data exist for this effect.
Cellular aging markers in laboratory cell studies
In a laboratory study of human skin fibroblasts, epsilon-viniferin lowered the reactive oxygen species made by mitochondria and selectively cleared cells that had entered a worn-out senescent state, restoring some markers of mitochondrial function. This was a single in-cell study with no equivalent testing in people.
Mechanism of action
Activates the energy sensor AMPK
In cells and in rodents, epsilon-viniferin switches on AMP-activated protein kinase (AMPK), a master sensor that cells use to balance energy. AMPK activation is the pathway researchers most often link to its reported effects on fat storage and on blood sugar and lipid measures in animals.
Supports mitochondria through SIRT3
Laboratory work shows epsilon-viniferin raises SIRT3, a protein inside mitochondria that helps manage energy use and oxidative balance. Through SIRT3 it appears to steady the mitochondrial membrane, support the making of new mitochondria and lower reactive oxygen species in stressed cells.
Direct free-radical scavenging
As a stilbene built from two resveratrol units, epsilon-viniferin carries several phenol groups that can donate hydrogen atoms to neutralize free radicals. This is measurable in simple chemical tests such as the DPPH assay, where its activity is weaker than that of vitamin E.
Low oral absorption and rapid handling
Epsilon-viniferin is poorly absorbed when swallowed. In the one human study that looked, none could be detected in blood or urine after an oral dose, and laboratory gut-cell models agree that very little crosses the gut wall. This is a major reason its laboratory effects may not carry over to people.
Clinical trials
Laboratory study screening stilbene compounds in cultured cells that carry a disease-linked mutant protein, testing effects on SIRT3, AMPK and mitochondria. (Fu et al. 2012, J Biol Chem)
Cultured cells; no people or whole animals were dosed.
Among 22 stilbenes screened, trans-epsilon-viniferin raised mitochondrial SIRT3, activated AMPK, increased signs of new mitochondria forming, lowered reactive oxygen species and preserved mitochondrial membrane potential. Blocking SIRT3 removed these effects. A cell study only, with no human or whole-animal data.
Laboratory study in human-derived SH-SY5Y nerve-type cells stressed with rotenone, testing the SIRT3 to FOXO3 pathway. (Zhang et al. 2020, Neural Regen Res)
Cultured human-derived nerve cells; no people were studied.
Epsilon-viniferin (1 micromolar for 24 hours) raised SIRT3, increased ATP production, lowered reactive oxygen species, steadied the mitochondrial membrane and reduced cell death. Silencing SIRT3 or FOXO3 reversed the effects. A single cell-model study, not evidence in people.
Animal study giving oral epsilon-viniferin to diabetic rats (high-fat diet plus streptozotocin) for 8 weeks, with AMPK measured in the liver. (Liu et al. 2020, Food Funct)
Laboratory rats with diet- and streptozotocin-induced type 2 diabetes; no human participants.
Oral epsilon-viniferin at 30 and 60 mg/kg was followed by lower fasting blood sugar, total cholesterol, triglycerides and LDL cholesterol, better glucose tolerance and higher AMPK activation in the liver, with liver and kidney blood markers also improved. An 8-week rat study; the results have not been reproduced in people.
Laboratory screen of plant compounds for control of mitochondrial reactive oxygen species in cultured human fibroblasts. (Park et al. 2025, Pharmaceuticals (Basel))
Cultured human skin fibroblasts; in vitro only.
Epsilon-viniferin lowered mitochondrial reactive oxygen species, acted as a senolytic that selectively removed worn-out senescent cells and restored some mitochondrial function, with the gene RGS16 identified as a mediator. An in-cell study with no human or animal testing.
Randomized single-dose crossover pharmacokinetic study in healthy volunteers comparing native and micellar grapevine-shoot extract. (Calvo-Castro et al. 2018, Mol Nutr Food Res)
12 healthy adults (6 women and 6 men).
After a single 500 mg dose of grapevine-shoot extract (supplying about 75 mg trans-epsilon-viniferin and 30 mg trans-resveratrol), no trans-epsilon-viniferin could be detected in blood or urine over 24 hours, while resveratrol absorption improved with a micellar form. No treatment-related adverse effects were reported. This measured absorption and safety, not any health outcome.
Laboratory isolation of resveratrol-dimer isomers from grape stems with a DPPH antioxidant assay. (Kong et al. 2016, J Sep Sci)
Chemical assay; no cells, animals or people.
Purified trans-epsilon-viniferin scavenged DPPH free radicals, but less strongly than its isomer trans-delta-viniferin, which in turn was slightly weaker than vitamin E at the same concentration. A test-tube antioxidant measure only.